Michael DiVecchia
Directeur des opérations chez Elicio Therapeutics, Inc. (Old)
Profil
Michael DiVecchia is currently working as the Vice President of Operations & Program Management at Elicio Therapeutics, Inc. (United States).
Previously, he held the position of Senior VP of Operations & Human Resources at Elicio Therapeutics, Inc. from 2022 to 2024.
He completed his undergraduate degree at Syracuse University.
Postes actifs de Michael DiVecchia
Sociétés | Poste | Début |
---|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Directeur des opérations | - |
Anciens postes connus de Michael DiVecchia
Sociétés | Poste | Fin |
---|---|---|
ELICIO THERAPEUTICS, INC. | Directeur des opérations | 01/01/2024 |
Formation de Michael DiVecchia
Syracuse University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ELICIO THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |